血管內碎石術市場商機、成長要素、產業趨勢分析及2026-2035年預測。

全球血管內碎石術（IVL）市場預計到 2025 年將達到 9.543 億美元，並以 15.8% 的複合年成長率成長，到 2035 年達到 40 億美元。

隨著對微創技術在改善鈣化血管疾病治療方面的需求不斷成長，血管內碎石術（IVL）市場正在快速擴張。人口老化和心血管代謝疾病發病率的上升導致動脈鈣化盛行率不斷攀升，這持續為市場成長創造有利環境。醫療專業人員擴大採用先進的血管準備技術，以提高介入心臟病學手術的成功率並最佳化患者預後。持續的臨床檢驗、主要醫療市場保險覆蓋範圍的擴大以及技術的不斷進步，正在加速IVL從一種新興治療選擇向廣泛接受的臨床解決方案的轉變。隨著全球老年人口的持續成長，需要治療複雜鈣化血管病變的患者數量也不斷增加。由於血管鈣化老齡化成長而加重，預計血管內碎石術的長期需求將保持結構性穩健，其支撐力在於持續的臨床需求，而非曇花一現的流行趨勢。這些因素進一步增強了全球血管內碎石術（IVL）市場的良好成長前景。

預計到2025年，血管內碎石導管和球囊將佔據82.84%的市場佔有率，市場規模達到7.906億美元。此產品類型維持主導地位的原因在於，所有血管內碎石術（IVL）都需要新的導管，持續產生耗材需求。相較之下，固定式醫療器材的使用週期較長，且可用於多種手術。對一次性器械的持續需求將繼續支撐強勁的產生收入，鞏固導管和球囊領域的市場主導地位，並在整個預測期內保持領先地位。

預計到2025年，醫院將佔據72.2%的市場佔有率，並創造6.885億美元的收入。醫院仍然是IVL技術的主要終端用戶，因為IVL手術需要專業的心血管治療設施、專用設備以及訓練有素的多學科臨床團隊。先進的心臟導管檢查室和血管介入中心在完善的患者照護基礎設施和成熟的報銷機制的支持下，繼續進行大量手術，這些都促進了IVL技術的持續應用。

預計到2025年，北美血管內碎石術（IVL）市場規模將達到3.97億美元，市佔率為41.6%。美國仍佔據該地區需求的大部分，這得益於有利的醫保政策、先進的醫療基礎設施、醫生對該技術的接受度不斷提高以及微創心血管手術的日益普及。臨床適應症的持續拓展和相關醫療政策的支持預計將在預測期內推動全部區域市場強勁成長。

目錄

第1章：調查方法

第2章執行摘要

第3章 行業洞察

• 產業生態系分析
• 影響產業的因素
  • 促進因素
    • 心血管疾病盛行率不斷上升
    • 微創技術的進步
    • 提高對靜脈輸液療法的認知與應用
    • 世界人口老化
  • 產業潛在風險與挑戰
    • 治療費用高昂
    • 併發症風險
    • 與還款相關的挑戰
  • 機會
    • 整合利用人工智慧的精密技術
    • 擴大新興市場的准入
• 成長潛力分析
• 監理情勢
• 價格趨勢分析
• 技術與創新展望
  • 最新科技趨勢
  • 新興技術
• 未來市場趨勢
• 專利分析
• 價格分析
• IVL手術及鈣化病灶治療計畫的發展趨勢
• 人工智慧和生成式人工智慧對市場的影響
• 波特的分析
• PESTLE分析

第4章 競爭情勢

• 介紹
• 企業矩陣分析
• 企業市佔率分析
  • 世界
  • 北美洲
  • 歐洲
  • 亞太地區
  • LAMEA
• 主要市場公司的競爭分析
• 競爭定位矩陣
• 主要進展
  • 併購
  • 夥伴關係和聯盟
  • 新產品發布
  • 業務拓展計劃

第5章 市場估算與預測：依產品類型分類，2022-2035年

• 血管內碎石導管和球囊
  • 冠狀動脈IVL球囊
  • 末梢用靜脈輸液球囊
• IVL 產生器/主機
• 附件和連接電纜

第6章 市場估計與預測：依應用領域分類，2022-2035年

• 冠狀動脈疾病（CAD）
  • 冠狀動脈鈣化病變
  • 左主幹冠狀動脈疾病
  • 支架內再血管再阻塞
• 周邊動脈疾病（PAD）
  • 髂動脈病變
  • 股膕動脈病變
  • 膝蓋以下部位的病變
• 其他血管相關應用

第7章 市場估計與預測：依年齡層別分類，2022-2035年

• 成年人（18-64歲）
• 老年人（65歲以上）

第8章 市場估算與預測：依最終用途分類，2022-2035年

• 醫院
• 門診手術中心
• 其他

第9章 市場估計與預測：依地區分類，2022-2035年

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 荷蘭
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • UAE

第10章：公司簡介

• Shockwave Medical Inc（Johnson & Johnson）
• Boston Scientific
• ABBOTT
• ELIXIR
• FASTWAVE MEDICAL
• Stryker（Amplitude Vascular Systems, Inc）
• PHILIPS
• MicroPort
• LEPU MEDICAL
• CAGENT VASCULAR

The Global Intravascular Lithotripsy (IVL) Market was valued at USD 954.3 million in 2025 and is estimated to grow at a CAGR of 15.8% to reach USD 4 billion by 2035.

The intravascular lithotripsy (IVL) market is witnessing rapid expansion as demand rises for minimally invasive technologies that improve the treatment of calcified vascular disease. The increasing prevalence of arterial calcification, driven by aging populations and the growing incidence of cardiometabolic disorders, continues to create favorable conditions for market growth. Healthcare providers are increasingly adopting advanced vessel preparation technologies to improve procedural success and optimize patient outcomes during interventional cardiovascular procedures. Continued clinical validation, expanding reimbursement support across major healthcare markets, and ongoing technological advancements are accelerating the transition of IVL from an emerging treatment option to a widely accepted clinical solution. As the global elderly population continues to increase, the number of patients requiring treatment for complex calcified vascular lesions is also expanding. Since vascular calcification becomes more common with advancing age, long-term demand for intravascular lithotripsy technologies is expected to remain structurally strong, supported by sustained clinical need rather than temporary adoption trends. These factors continue to reinforce favorable growth prospects for the global intravascular lithotripsy (IVL) market.

Intravascular lithotripsy catheters and balloons accounted for 82.84% share in 2025, representing USD 790.6 million. This product category maintains its leading position because every IVL procedure requires the use of a new catheter, creating recurring demand for consumable products. In contrast, capital equipment is utilized across multiple procedures over an extended period. The consistent need for single-use devices continues to support strong revenue generation and reinforces the dominance of the catheter and balloon segment throughout the forecast period.

The hospitals segment held 72.2% share in 2025, generating USD 688.5 million. Hospitals remain the primary end users because IVL procedures require specialized cardiovascular treatment facilities, dedicated procedural equipment, and highly trained multidisciplinary clinical teams. Advanced cardiac catheterization laboratories and vascular intervention centers continue to perform many procedures, supported by a comprehensive patient care infrastructure and established reimbursement pathways that encourage continued adoption of IVL technology.

North America Intravascular Lithotripsy (IVL) Market accounted for 41.6% share in 2025, representing USD 397 million. The United States continues to contribute most of the regional demand, supported by favorable reimbursement policies, advanced healthcare infrastructure, growing physician adoption, and increasing utilization of minimally invasive cardiovascular procedures. Continued expansion of clinical applications and supportive healthcare policies is expected to sustain strong market growth across the region throughout the forecast period.

Major companies operating in the global intravascular lithotripsy (IVL) market include Boston Scientific, Abbott, Philips, Shockwave Medical Inc. (Johnson & Johnson), Stryker (Amplitude Vascular Systems, Inc.), Elixir Medical, FastWave Medical, Cagent Vascular, LEPU Medical, and MicroPort. Companies operating in the intravascular lithotripsy (IVL) market are strengthening their competitive position by investing in research and development to enhance device performance, improve procedural efficiency, and expand clinical applications. Manufacturers continue to focus on product innovation, technological advancement, and the development of next-generation treatment solutions that address increasingly complex vascular conditions. Strategic collaborations with healthcare institutions, clinical research organizations, and distribution partners are supporting broader commercial adoption and market expansion. Companies are also increasing investments in regulatory approvals, manufacturing capacity, physician training, and global geographic expansion to improve market access.

Table of Contents

Chapter 1 Research Methodology

• 1.1 Market definitions and scope
• 1.2 Research approach
• 1.3 Quality commitments
  • 1.3.1 GMI AI policy & data integrity commitment
    • 1.3.1.1 Source consistency protocol
• 1.4 Research trail & confidence scoring
  • 1.4.1 Research trail components
  • 1.4.2 Scoring components
• 1.5 Data collection
  • 1.5.1 Partial list of primary sources
• 1.6 Data mining sources
  • 1.6.1 Paid sources
    • 1.6.1.1 Sources, by region
• 1.7 Base estimates and calculations
  • 1.7.1 Base year calculation
• 1.8 Forecast model
  • 1.8.1 Quantified market impact analysis
    • 1.8.1.1 Mathematical impact of growth parameters on forecast
• 1.9 Research transparency addendum
  • 1.9.1 Source attribution framework
  • 1.9.2 Quality assurance metrics
  • 1.9.3 Our commitment to trust

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis
• 2.2 Key market trends
  • 2.2.1 Regional trends
  • 2.2.2 Product type trends
  • 2.2.3 Application trends
  • 2.2.4 Age group trends
  • 2.2.5 End use trends
• 2.3 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising prevalence of cardiovascular diseases
    • 3.2.1.2 Advancements in minimally invasive technologies
    • 3.2.1.3 Growing awareness and adoption of IVL
    • 3.2.1.4 Increasing aging global population
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of procedures
    • 3.2.2.2 Risk of complications
    • 3.2.2.3 Reimbursement challenges
  • 3.2.3 Opportunities
    • 3.2.3.1 Integration of AI-driven precision technologies
    • 3.2.3.2 Growing access in emerging markets
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Pricing trend analysis
• 3.6 Technology and innovation landscape (Driven by Primary Research)
  • 3.6.1 Current technological trends
  • 3.6.2 Emerging technologies
• 3.7 Future market trends (Driven by Primary Research)
• 3.8 Patent analysis
• 3.9 Pricing analysis
• 3.10 IVL procedure volume trends & calcified lesion treatment pipeline (Driven by Primary Research)
• 3.11 Impact of AI & Generative AI on the Market (Driven by Primary Research)
• 3.12 Porter's analysis
• 3.13 PESTEL analysis

Chapter 4 Competitive Landscape, 2025

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis (Driven by Primary Research)
  • 4.3.1 Global
  • 4.3.2 North America
  • 4.3.3 Europe
  • 4.3.4 Asia Pacific
  • 4.3.5 LAMEA
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers & acquisitions
  • 4.6.2 Partnerships & collaborations
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product Type, 2022 - 2035 ($ Mn)

• 5.1 Key trends
• 5.2 Intravascular lithotripsy catheters and balloons
  • 5.2.1 Coronary IVL balloons
  • 5.2.2 Peripheral IVL balloons
• 5.3 IVL generators / consoles
• 5.4 Accessories & connector cables

Chapter 6 Market Estimates and Forecast, By Application, 2022 - 2035 ($ Mn)

• 6.1 Key trends
• 6.2 Coronary artery disease (cad)
  • 6.2.1 Calcified coronary lesions
  • 6.2.2 Left main coronary artery disease
  • 6.2.3 In-stent restenosis
• 6.3 Peripheral artery disease (PAD)
  • 6.3.1 Iliac artery lesions
  • 6.3.2 Femoral-popliteal lesions
  • 6.3.3 Infrapopliteal lesions
• 6.4 Other vascular applications

Chapter 7 Market Estimates and Forecast, By Age Group, 2022 - 2035 ($ Mn)

• 7.1 Key trends
• 7.2 Adult (18–64 Years)
• 7.3 Geriatric (65+ Years)

Chapter 8 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

• 8.1 Key trends
• 8.2 Hospitals
• 8.3 Ambulatory surgical centers
• 8.4 Others

Chapter 9 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 MEA
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 Shockwave Medical Inc (Johnson & Johnson)
• 10.2 Boston Scientific
• 10.3 ABBOTT
• 10.4 ELIXIR
• 10.5 FASTWAVE MEDICAL
• 10.6 Stryker (Amplitude Vascular Systems, Inc)
• 10.7 PHILIPS
• 10.8 MicroPort
• 10.9 LEPU MEDICAL
• 10.10 CAGENT VASCULAR